Unveiling Potential: Exploring Alpha Emitter Radiopharmaceuticals
XTalks
JANUARY 19, 2024
In 2023, there have been pivotal trends shaping the landscape and application of alpha emitter therapy. The discussion centered on the evolving potential of alpha particle therapy for treating advanced and metastatic tumors. Common radionuclides used in alpha therapy include radium-223, actinium-225 and bismuth-213.
Let's personalize your content